The Swiss voice in the world since 1935
Top stories
Stay in touch with Switzerland

Swiss court forces Covid vaccine procurement transparency

Full transparency from the FOPH on Covid-19 vaccines
Full transparency from the FOPH on Covid-19 vaccines Keystone-SDA

The Swiss Federal Office of Public Health (FOPH) has been forced to publish unredacted contracts for procuring Covid vaccines during the pandemic.

+Get the most important news from Switzerland in your inbox

The move follows a February court ruling that obliged the government to publish the contracts with Moderna and Navax without redactions.

The FOPH has decided not to lodge an appeal against the transparency ruling.

The plaintiffs had requested access, under the Transparency Act, to the contracts concluded by the FOPH and the army pharmacy for the Covid vaccines. This request was rejected by the Federal Office at the end of 2023.

In 2022, the FOPH published the contracts concluded with the vaccine manufacturers Moderna, Novavax, Pfizer, Janssen, AstraZeneca and CureVac only after redacting them.

The move was prompted by fears that disclosure of the contracts only in Switzerland would place Switzerland at a negotiating disadvantage when it comes to supplying vaccines in the event of a future pandemic.

Nearly a billion dollars

According to the FOPH, Switzerland was able to reserve the first 4.5 million doses of vaccine from Moderna in August 2020. By the end of the Covid pandemic, this figure had risen to 31 million doses of mRNA vaccine at a cost of around $32 per dose. This equated to a financial commitment of around $980 million.

According to the FOPH, one million doses of Novavax protein vaccine have been reserved for December 2021 at a price of $22 per dose. Switzerland paid around $20 million for these vaccines.

Adapted from German by AI/mga

We select the most relevant news for an international audience and use automatic translation tools to translate them into English. A journalist then reviews the translation for clarity and accuracy before publication.  

Providing you with automatically translated news gives us the time to write more in-depth articles. The news stories we select have been written and carefully fact-checked by an external editorial team from news agencies such as Bloomberg or Keystone.

If you have any questions about how we work, write to us at english@swissinfo.ch

External Content

Related Stories

Popular Stories

In compliance with the JTI standards

More: SWI swissinfo.ch certified by the Journalism Trust Initiative

You can find an overview of ongoing debates with our journalists here . Please join us!

If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR

SWI swissinfo.ch - a branch of Swiss Broadcasting Corporation SRG SSR